SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012614
Filing Date
2016-04-27
Accepted
2016-04-27 16:05:29
Documents
3
Period of Report
2016-06-29
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228438zdef14a.htm DEF 14A 308150
2 G89922BGI001.GIF g89922bgi001.gif GRAPHIC 69903
3 G89922BGI002.GIF g89922bgi002.gif GRAPHIC 54994
  Complete submission text file 0001047469-16-012614.txt   481430
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37566 | Film No.: 161595361
SIC: 2834 Pharmaceutical Preparations